Actively Recruiting
Biobank for Inflammatory Chronic Diseases and Osteoporosis of Toulouse University Hospital
Led by University Hospital, Toulouse · Updated on 2026-03-19
2000
Participants Needed
1
Research Sites
260 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to create a biobank for patients with chronic inflammatory rheumatism, including rheumatoid arthritis (RA), spondyloarthritis (SpA), and psoriatic arthritis (PsA), as well as those with osteoporosis. The goal is to identify biomarkers linked to how well patients respond to treatments, helping doctors make better treatment choices. The study is observational and sponsored by the University Hospital of Toulouse. Participants include patients beginning new biologic or targeted synthetic disease-modifying anti-rheumatic drugs (bDMARDs and tsDMARDs) for their conditions, as well as those with osteoporosis starting anti-osteoporotic treatments. Blood samples will be collected to study potential biomarkers. This biobank will support research on treatment response and disease severity. Participants will provide blood samples during the study. Researchers will measure treatment response using the European League Against Rheumatism (EULAR) response criteria after three months. The study involves follow-up to track biomarkers and treatment outcomes. The total participation period and specific visit schedules vary according to patient treatment and condition.
CONDITIONS
Brief Title
Biobank for Inflammatory Chronic Diseases and Osteoporosis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 to 99 years
- Diagnosed with chronic inflammatory rheumatism including rheumatoid arthritis, spondyloarthritis, or psoriatic arthritis, or with primary or secondary osteoporosis
- Covered by National Health Assurance
- Able to provide informed consent
You will not qualify if you...
- Pregnant or breastfeeding
- Unable to provide informed consent
- Severe anemia with hemoglobin less than 10 g/L
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Ongoing during the study period
Participants provide blood samples for the biobank to study biomarkers associated with chronic inflammatory diseases and osteoporosis.
1 baseline visit and 1 follow-up visit at 3 months
Duration - Up to 5 years
Participants are observed to assess clinical outcomes and biomarker associations related to disease severity and treatment response.
Periodic visits depending on clinical follow-up
Trial Site Locations
Total: 1 location
1
Purpan University Hospital
Toulouse, France, 31059
Actively Recruiting
Research Team
A
Adeline RUYSSEN-WITRAND, MD
D
Delphine THUILLEZ
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here